Hawaii Minority-Based Clinical Community Oncology Program

夏威夷少数民族临床社区肿瘤学计划

• 批准号: 7892615
• 负责人: Jeffrey Lee Berenberg
• 金额: $ 83.73万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-08-01 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7892615
• 关键词: Age; Cancer Burden; Cancer Patient; Cancer Research Center of Hawaii; Clinical Oncology; Clinical Research; Clinical Trials; Communities; Controlled Clinical Trials; Controlled Study; Data; Ethnic Origin; Gender; Gynecologic Oncology Group; Hawaii; Health Personnel; Hospitals; Incidence; Individual; Institution; Island; Malignant Neoplasms; Medical; Minority; Minority-Based Community Clinical Oncology Program; Morbidity - disease rate; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Oncologist; Patients; Physicians; Population; Prevention; Primary Health Care; Progress Reports; Radiation Therapy Oncology Group; Research; Science; Source; Southwest Oncology Group; Specialist; Symptoms; Underserved Population; base; cancer prevention; cancer therapy; data management; ethnic minority population; high risk; medical specialties; mortality; success; treatment effect

DESCRIPTION (provided by applicant): The primary objective of the Hawaii Minority-Based Community Clinical Oncology (MBCCOP) is to build on its past 15 year success in providing National Cancer Institute (NCI) clinical trials to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity and mortality by: 1. providing support to expand clinical research in the State of Hawaii, a multiethnic population with a majority of ethnic minority patients; 2. bringing the advantages of state-of-the-science treatment and prevention/control research to minority individuals in their own communities; 3. facilitating broader participation among underserved populations in NCI-approved research; 4. strengthening the operational base that presently exists to extend cancer prevention and control research in the population; 5. increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention, and control studies. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MBCCOP and will direct recruitment, accrual, and data management for NCI-approved cancer treatment, prevention and symptom control clinical trials. Sources of clinical trials include: SWOG, GOG, COG, RTOG, URCC, CTSU, and NSABP prevention trials. Participating physicians include oncologists on Oahu, Kauai, Maui, and the Big Island of Hawaii as well as professionals from other medical and non-medical specialties. All major hospitals in the state will serve as component/affiliate institutions. The MBCCOP will allow the people of Hawaii, about 75% who are ethnic minorities, to benefit from access to state-of-the-science cancer treatment, prevention and symptom control studies while providing valuable clinical research data on a unique population. RELEVANCE: Provide access to NCI-approved cancer treatment, prevention and control clinical trials for the people of Hawaii especially for minorities and under-served populations. Lower the burden of cancer in the State of Hawaii. Provide data on differences in cancer incidence, morbidity, mortality and treatment effects as a function of ethnicity, gender, and age.

描述（由申请人提供）：夏威夷少数民族社区临床肿瘤学（MBCCOP）的主要目标是在过去15年成功向夏威夷癌症患者和高风险个体提供国家癌症研究所（NCI）临床试验的基础上，以降低癌症发病率、发病率和死亡率：1.为扩大夏威夷州的临床研究提供支持，夏威夷州是一个多民族的国家，少数民族患者占多数; 2.将最先进的治疗和预防/控制研究的优势带给自己社区的少数群体; 3.促进服务不足人群更广泛地参与国家癌症研究所批准的研究; 4.加强现有的业务基础，以扩大人口中的癌症预防和控制研究; 5.增加初级卫生保健提供者和其他专家对癌症治疗、预防和控制研究的参与。夏威夷癌症研究中心将作为MBCCOP的行政总部，并将指导NCI批准的癌症治疗、预防和症状控制临床试验的招募、应计和数据管理。临床试验的来源包括：SWOG，GOG，COG，RTOG，URCC，CTSU和NSABP预防试验。参与的医生包括奥廷加、考艾岛、毛伊岛和夏威夷大岛的肿瘤学家以及其他医学和非医学专业的专业人员。该州所有主要医院都将作为组成/附属机构。MBCCOP将使夏威夷人民（约75%为少数民族）受益于获得最先进的癌症治疗、预防和症状控制研究，同时提供关于独特人群的宝贵临床研究数据。 相关性：为夏威夷人民，特别是少数民族和服务不足的人群提供获得国家癌症研究所批准的癌症治疗、预防和控制临床试验的机会。降低夏威夷州的癌症负担。提供关于癌症发病率、发病率、死亡率和治疗效果差异的数据，作为种族、性别和年龄的函数。